About Anushka Dutta
With a master's degree in economics, she aims to help investors identify untapped investment opportunities by looking at the fundamental factors.
Recent Articles By Anushka Dutta
Is Clear Secure (YOU) the Right Investment for Secure Returns?
With strong capital allocation commitments and strong recent results, is Clear Secure (YOU) the right investment at the moment? Let’s look at its financial metrics to gauge its prospects…
Analyzing Workday (WDAY) Q3 Earnings: Is December the Right Time to Invest?
After a solid financial performance in the third-quarter results released this week, does Workday (WDAY) deserve a place in your portfolio in December? Let’s look at its financial metrics to know more…
Ulta Beauty (ULTA) Pre-Earnings Breakdown
Beauty retailer Ulta Beauty (ULTA) is set to report its earnings today. Does it have the ability to capitalize on the holiday season rush? Let’s look at its financial metrics to know more…
Dell Technologies Inc. (DELL) Earnings Spotlight: Tech Stock Gameplan
Projecting a demand boom for its offerings due to the hype surrounding generative AI, does Dell Technologies (DELL) deserve a place in your portfolio before its third-quarter earnings release? Let’s look at its financial metrics to gauge its prospects…
3 Software Stocks to Program Productive Gains in December
As the software industry evolves with transformative trends such as AI-driven development, fundamentally strong software stocks Agilysys (AGYS), Docebo (DCBO), and MarketWise (MKTW) might be solid investments next month. Read more…
3 Medical Stocks to Inject Future Investments Into Your Portfolio
The healthcare sector is undergoing transformation amid expenditure growth and tech advances. Hence, fundamentally strong medical stocks, McKesson Corp. (MCK), Encompass Health (EHC), and USANA Health Sciences (USNA), might be solid investments now for garnering potential gains. Read more…
Can Cirrus Logic, Inc. (CRUS) Capitalize on the Chip Industry Boom?
The semiconductor industry is beaming with possibilities in the digital era. Does that mean Cirrus Logic (CRUS), post its mixed quarterly results, is a buy? Let’s look at its financial metrics to know more…
Why Masco Corporation (MAS) Stands Out as a Prime Building Products Investment
Despite posting mixed results for the third quarter, Masco Corporation’s (MAS) outlook remains positive. The stock could be a solid buy now. Let’s look at MAS’ financial metrics to know why…
3 Biotech Stocks to Buy to Help the Health of Your Portfolio
Amid the dynamic biotech landscape, the sector is set to witness substantial growth fueled by multiple advancements. Hence, fundamentally strong biotech stocks ANI Pharmaceuticals (ANIP), Exelixis (EXEL), and Entrada Therapeutics (TRDA) might be solid investments now. Read more…